• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际临床化学联合会载脂蛋白A-I和B测定标准化项目。II. 候选参考物质的评估与选择

International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials.

作者信息

Albers J J, Marcovina S M, Kennedy H

机构信息

Department of Medicine, University of Washington, Seattle 98103.

出版信息

Clin Chem. 1992 May;38(5):658-62.

PMID:1582016
Abstract

The first phase of an international collaborative study for standardization of test systems for measuring apolipoprotein (apo) A-I and apo B demonstrated that uniformity of apo A-I and apo B measurements can be achieved if suitable common reference materials are used to calibrate the different systems. The objective of the second phase was to evaluate the linearity and parallelism or proportionality of the candidate reference materials selected in phase one and to determine whether any of them could be proposed as international reference materials. We evaluated the proposed reference materials with 37 test systems for apo A-I and 38 for apo B, involving 23 manufacturers and five research laboratories. Two lyophilized preparations were proposed for apo A-I, SP1 from Behringwerke AG and SP2 from Daiichi Pure Chemicals Co., and two liquid preparations were proposed for apo B, SP3 from Behringwerke AG and SP4 from Reagents Applications. The linearity of the candidate reference materials was compared with the linearity of a frozen serum pool or interim serum reference material distributed to all the participants and with that of a fresh serum pool prepared by each participant. SP1 and SP3 exhibited linearity and parallelism similar to that of the fresh frozen serum pool and had among-laboratory CVs less than or similar to those obtained on normolipidemic serum samples (approximately 6% for apo A-I and approximately 7% for apo B).

摘要

一项用于测量载脂蛋白(apo)A-I和apo B的检测系统标准化的国际合作研究的第一阶段表明,如果使用合适的通用参考物质来校准不同系统,就能实现apo A-I和apo B测量的一致性。第二阶段的目标是评估在第一阶段选定的候选参考物质的线性度、平行度或比例关系,并确定其中是否有任何一种可以被提议作为国际参考物质。我们使用37种检测apo A-I的系统和38种检测apo B的系统对提议的参考物质进行了评估,涉及23家制造商和5个研究实验室。针对apo A-I提议了两种冻干制剂,即德国贝林公司的SP1和第一制药株式会社的SP2;针对apo B提议了两种液体制剂,即德国贝林公司的SP3和试剂应用公司的SP4。将候选参考物质的线性度与分发给所有参与者的冷冻血清混合样本或临时血清参考物质的线性度以及每个参与者制备的新鲜血清混合样本的线性度进行了比较。SP1和SP3表现出与新鲜冷冻血清混合样本相似的线性度和平行度,实验室间变异系数小于或类似于在血脂正常血清样本上获得的变异系数(apo A-I约为6%,apo B约为7%)。

相似文献

1
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. II. Evaluation and selection of candidate reference materials.国际临床化学联合会载脂蛋白A-I和B测定标准化项目。II. 候选参考物质的评估与选择
Clin Chem. 1992 May;38(5):658-62.
2
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B.国际临床化学联合会载脂蛋白A-I和B测量标准化项目
Clin Chem. 1991 Oct;37(10 Pt 1):1676-82.
3
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material.国际临床化学联合会载脂蛋白A-I和B测定标准化项目。IV. 使用国际参考物质时载脂蛋白B值的可比性。
Clin Chem. 1994 Apr;40(4):586-92.
4
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material.国际临床化学联合会载脂蛋白A-I和B测定标准化项目。III. 使用国际参考物质时载脂蛋白A-I值的可比性。
Clin Chem. 1993 May;39(5):773-81.
5
Standardization of commercial assays for serum Apo A-I and Apo B: a consensus procedure for the calibration of reference materials.血清载脂蛋白A-I和载脂蛋白B商业检测方法的标准化:参考物质校准的共识程序。
Scand J Clin Lab Invest Suppl. 1990;198:73-9.
6
An international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material.载脂蛋白A-I和B标准化的国际合作研究。第一部分。冻干候选参考物质和校准物质的评估。
Clin Chem. 1987 Dec;33(12):2240-9.
7
Effects of analytical method and lyophilized sera on measurements of apolipoproteins A-I and B: an international survey.分析方法和冻干血清对载脂蛋白A-I和B测量结果的影响:一项国际调查。
Clin Chem. 1990 Feb;36(2):290-6.
8
Measurement of apolipoproteins A-I and B during the National Health and Nutrition Examination Survey (NHANES) III.美国国家健康与营养检查调查(NHANES)III期间载脂蛋白A-I和B的测量。
Clin Chem. 1994 Oct;40(10):1915-20.
9
An international collaborative study on standardization of apolipoproteins A-I and B. Part II. Evaluation of contributions of antisera to among-laboratory variance components.载脂蛋白A-I和B标准化的国际协作研究。第二部分。抗血清对实验室间方差成分贡献的评估。
Clin Chem. 1987 Dec;33(12):2250-6.
10
Evaluation of a turbidimetric procedure for apolipoproteins A1 and B on the Ciba Corning 550 EXPRESS.在Ciba Corning 550 EXPRESS上对载脂蛋白A1和B的比浊法检测评估。
Clin Biochem. 1993 Dec;26(6):477-82. doi: 10.1016/0009-9120(93)80012-j.

引用本文的文献

1
Development and Validation of Multiple Equations for Low-Density Lipoprotein and Apolipoprotein B in Korean Patients Visiting Local Clinics and Hospitals.开发并验证适用于在当地诊所和医院就诊的韩国患者的 LDL 和载脂蛋白 B 的多套方程。
Nutrients. 2023 Jun 17;15(12):2786. doi: 10.3390/nu15122786.
2
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science.利用先进血脂检测评估动脉粥样硬化性心血管疾病风险:科学现状
Eur Cardiol. 2020 Jul 15;15:e56. doi: 10.15420/ecr.2019.18. eCollection 2020 Feb.
3
Reference Materials for the Standardization of the Apolipoproteins A-I and B, and Lipoprotein(a).
载脂蛋白A-I、B及脂蛋白(a)标准化的参考物质
EJIFCC. 2001 Dec 23;13(3):73-79. eCollection 2001 Dec.
4
Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.高密度脂蛋白胆固醇与载脂蛋白A-I 与冠心病风险的关联:欧洲癌症前瞻性调查-诺福克前瞻性人群研究、社区动脉粥样硬化风险研究以及妇女健康研究
J Am Heart Assoc. 2017 Aug 3;6(8):e006636. doi: 10.1161/JAHA.117.006636.
5
Visual Function in Older Eyes in Normal Macular Health: Association with Incident Early Age-Related Macular Degeneration 3 Years Later.正常黄斑健康状况下老年眼睛的视觉功能:与三年后发生的早期年龄相关性黄斑变性的关联
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1782-9. doi: 10.1167/iovs.15-18962.
6
Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health.正常黄斑健康的老年人中,异常视杆细胞介导的暗适应与健康及功能之间的关联。
Invest Ophthalmol Vis Sci. 2014 May 22;55(8):4776-89. doi: 10.1167/iovs.14-14502.
7
The role of advanced lipid testing in the prediction of cardiovascular disease.高级血脂检测在心血管疾病预测中的作用。
Curr Atheroscler Rep. 2014 Mar;16(3):394. doi: 10.1007/s11883-013-0394-9.
8
Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study.脂蛋白(a)与冠心病、脑血管病和外周动脉疾病风险:EPIC-Norfolk 前瞻性人群研究。
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3058-65. doi: 10.1161/ATVBAHA.112.255521. Epub 2012 Oct 11.
9
Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study.健康女学生中载脂蛋白 B、载脂蛋白 A1 及载脂蛋白 B/载脂蛋白 A1 比值的决定因素:辛辛那提国家生长与健康研究,前瞻性研究,平均年龄 10 至 19 岁。
Metabolism. 2012 Oct;61(10):1377-87. doi: 10.1016/j.metabol.2012.02.014. Epub 2012 Apr 16.
10
Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research.验证用于非人灵长类动物血脂异常和动脉粥样硬化研究的人载脂蛋白 B 和载脂蛋白 AI 免疫比浊测定法。
J Cardiovasc Transl Res. 2011 Jun;4(3):373-83. doi: 10.1007/s12265-011-9264-4. Epub 2011 Mar 11.